Outset Medical, Inc. OM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 40.6%+4.7pp | 39.1%+5.2pp | 37.7%+6.7pp | 36.5%+8.2pp | 35.9%+11.3pp | |
| Operating margin | -57.2%+23.4pp | -55.8%+43.9pp | -59.1%+53.2pp | -66.2%+63.1pp | -80.6%+49.9pp | |
| Net margin | -63.7%+35.1pp | -68.3%+44.2pp | -73.1%+49.7pp | -82.1%+54.7pp | -98.7%+36.2pp | |
| Returns | ||||||
| Return on equity | -53.2%+33.4pp | -106.2%+64.8pp | -92.3%+48.7pp | -87.7%+38.8pp | -86.5%+22.5pp | |
| Return on invested capital | -35.9%+4.9pp | -44.8%+32.0pp | -33.7%+25.5pp | -35.4%+26.9pp | -40.8%+19.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×+0.1× | 0.4×+0.1× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 6.3×-2.1× | 6.7×+1.0× | 7.1×+0.6× | 7.5×+0.7× | 8.4×+2.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×+0.3× | 0.8×-6.7× | 0.7×-3.5× | 0.6×-2.3× | 0.6×-1.6× | |
| Per Share | ||||||
| Book value per share | $6.08-74.8% | $8.35+7.8% | $8.01-41.7% | $8.72-56.0% | $24.14-12.1% | |
| Valuation | ||||||
| Market capitalization | $80.08M-77.6% | $67.35M-76.6% | $250.86M+45.0% | $353.91M-63.3% | $195.76M-64.4% | |
| Price / sales | 0.7×-2.3× | 0.6×-2.0× | 2.1×+0.6× | 3×-5.3× | 1.7×-2.7× | |
| Price / book | 0.7×-1.6× | 0.5×-10.2× | 1.8×-1.9× | 2.3×-11.8× | 1.2×-4.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Outset Medical, Inc.'s profit margins?
- Outset Medical, Inc. (OM) runs a 40.6% gross margin and a -57.2% operating margin, with a -63.7% net margin.
- Where do Outset Medical, Inc.'s ratios come from?
- Every ratio is computed from Outset Medical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
